Siblings 圖書 [0/1] 專利 [0/1] 期刊論文 [107/108] Collection Statistics 近3年內發表的文件:10(32.26%) 含全文筆數:30(96.77%) 文件下載次數統計 下載大於0次:30(100.00%) 下載大於100次:20(66.67%) 檔案下載總次數:11311(19.72%) 最後更新時間: 2025-04-17 22:54 上傳排行 資料載入中..... 下載排行 資料載入中..... 最近上傳 Brain neuronal integrity in Covid-1... The effect of dopamine receptor D1 ... D-amino acid oxidase correlation wi... Explore the role of growth factor F... Neurofilament light chain as a pote... A new hope for multiple system atro... Explore the role of inflammatory pa... More pronounced neuroaxonal integri... Biomarkers as potential indicators ... Cognitive frailty: A prospective ob...

跳至: (選擇年份) 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1985 1980 1975 1970 1960 1950 (選擇月份) January February March April May June July August September October November December 或輸入年份:

由新到舊排序 由最舊的開始

顯示項目1-25 / 31. (共2頁) 1 2 > >> 每頁顯示[10|25|50]項目

日期	題名	關聯
2025-02-12	More pronounced neuroaxonal integrity disturbances in methamphetamine-associated persistent psychosis compared to schizophrenia	International Journal of Neuropsychopharmacology. 2025 Feb 12;28(Suppl. 1):i96-i97.
2025-02-12	Explore the role of inflammatory pathway of Tnfr1 in alcohol dependence and the potential to differentiate delirium tremens	International Journal of Neuropsychopharmacology. 2025 Feb 12;28(Suppl. 1):i297-i298.
2025-02-12	A new hope for multiple system atrophy: A translational research of a novel nmdar receptor modulator from preclinical models to patients	International Journal of Neuropsychopharmacology. 2025 Feb 12;28(Suppl. 1):i76-i77.
2025-02-12	Neurofilament light chain as a potential indicator of delirium tremens among patients with alcohol dependence	International Journal of Neuropsychopharmacology. 2025 Feb 12;28(Suppl. 1):I95-I96.
2025-02-12	Explore the role of growth factor Fgf2 in alcohol dependence	International Journal of Neuropsychopharmacology. 2025 Feb 12;28(Suppl. 1):i97-i98.
2025-02-12	The effect of dopamine receptor D1 (Drd1) gene variants on changes in craving severity during alcohol withdrawal	International Journal of Neuropsychopharmacology. 2025 Feb 12;28(Suppl. 1):i11-i12.
2025-02-12	Brain neuronal integrity in Covid-19 patients in Taiwan	International Journal of Neuropsychopharmacology. 2025 Feb 12;28(Suppl. 1):i130.
2025-02-12	D-amino acid oxidase correlation with neurofilament light chain in covid-infectedpatients	International Journal of Neuropsychopharmacology. 2025 Feb 12;28(Suppl. 1):i127-i128.
2023-07	Cognitive frailty: A prospective observational cohort study from aged 60 to 66	British Journal of Pharmacology. 2023 Jul;180(Suppl. 1):254.
2023-07	Biomarkers as potential indicators for substance use disorder patient care	British Journal of Pharmacology. 2023 Jul;180(Suppl. 1):273-273.
2019-10	Investigation the main effects of genetic variants and polygenic risk score of personality on suicidal behavior	European Neuropsychopharmacology. 2019 Oct;29:S146-S147.
2019-08	Genomewide sex-by-snp interaction scan identifies adgrv1 for the sex differences of opioid dependence in african american and supporting evidence in relations with treatment side effects in the asian population	European Neuropsychopharmacology. 2019 Aug;29(Suppl. 4):S1183-S1184.
2019-01	Identifying variants in nf1a gene to be associated with seasonal pattern and susceptibility for depression through a candidate gene approach	European Neuropsychopharmacology. 2019 Jan;29(Suppl. 3):S857-S858.
2019-01	Distinct genetic profiles of peptic ulcer in individuals with depression	European Neuropsychopharmacology. 2019 Jan;29(Suppl. 3):S905-S906.
2019-01	Identification of genetic variants for suicidal behaviors in patients with bipolar or major depressive disorders	European Neuropsychopharmacology. 2019 Jan;29(Suppl. 3):S988-S989.
2017-10	Identification of genetic loci for treatment response of selective serotonin reuptake inhibitors on empirically defined depression syndromal factors	European Neuropsychopharmacology. 2017 Oct;27:S390.
2017-05	Genome-wide association study of treatment emergent suicidal ideation with antidepressant use	Bipolar Disorders. 2017 May;19(Suppl. 1):113-114.
2016-10	Apoptosis pathway CASP10 gene associated with methadone dose and interacted with GRK5	European Neuropsychopharmacology. 2016 Oct;26(Suppl. 2):S693-S694.
2015-01	Change of suicidality among heroin users: 1 month after methadone maintenance treatment	Drug and Alcohol Dependence. 2015 Jan;146:e17.
2013-04	Comparing multiple testing correction methods between two softwares for single nucleotide polymorphisms association analyses: Using OPRD1 and diastolic blood pressure in methadone maintenance patients as an example	2013 IEEE Symposium on Computational Intelligence in Bioinformatics and Computational Biology (CIBCB). 2013 Apr:154-159.
2012-03	CYP1A2 genetic polymorphisms associated with antidepressant escitalopram metabolism and adverse reactions at early stage	Clinical Pharmacology and Therapeutics. 2012 Mar;91(Suppl. 1):S62.
2011-05	The genetic polymorphisms in ALDH2 influence the methadone dose and adverse reactions in patients with heroin addiction	Drug Metabolism Reviews. 2011 May;43(Suppl.1):26.
2011-05	Genetic polymorphisms of CYP2C19 associated with the side effect and serum concentrations of antidepressant paroxetine	Drug Metabolism Reviews. 2011 May;43(Suppl.1):25-26.
2011-05	Genetic polymorphisms in PXR associated with serum concentration and metabolism to treatment with the antidepressant paroxetine	Drug Metabolism Reviews. 2011 May;43(Suppl.1):71.
2011-05	CACNG2 is associated with delusion-hallucination symptom dimension of schizophrenia, but not with clozapine treatment outcome	Biological Psychiatry. 2011 May;69(9 Suppl. 1):281S.

顯示項目1-25 / 31. (共2頁) 1 2 > >> 每頁顯示[10|25|50]項目